Abstract:Feline herpesvirus-1 (FHV-1) infection occurs worldwide and is a leading cause of respiratory and ocular diseases in cats. Current vaccines reduce the severity of symptoms but do not prevent infection and, therefore, do not provide defense against an establishment of latency and reactivation. We hypothesize that immunomodulation of FHV-1 is the cause of lack in protection and that deletion of virulence/immune modulatory genes of FHV-1 will enhance safety and immunogenicity. Our objective was to use feline respiratory epithelial cell (FREC) cultures to define in vitro growth characteristics and immunomodulation resulting from infection of FRECs with the virulent FHV-1 strain C27 (WT) and glycoprotein C-deletion (gC-), glycoprotein E-deletion (gE-), serine/threonine protein kinase-deletion (PK-), as well as gE and thymidine kinase-double-deletion (gE-TK-) mutants generated by bacterial artificial chromosome mutagenesis. Differentiated FRECs were mock inoculated or inoculated with WT, gC-, gE-, PK-, or gE-TK- mutants. Virus titration and real-time quantitative PCR assays were performed on samples collected at 1 hpi followed by 24 h intervals between 24 and 96 hpi to determine growth kinetics. Real-time PCR was used to quantitate IFNα, TNFα, IL-1β, IL-10, and TGFβ-specific mRNA levels. Immunoassays were performed to measure the protein levels of subsets of cytokines/chemokines secreted by FRECs. Inoculation of FRECs with gE-TK- resulted in significantly lower end-point titers than inoculation with WT or gE-. Both PK- and gC- inoculated FRECs also produced significantly lower end-point titers at 96 hpi than WT. Overall, intracellular virus titers were higher than those of extracellular virus. PCR results for viral DNA paralleled the virus titration results. Further, in contrast to WT inoculation, an increase in IFNα and IL-10 mRNA expression was not observed following inoculation with gE-TK- and PK-, but inoculation with gE-TK- and PK- did result in increased TGFβ expression in FRECs compared to responses following infection with WT. Moreover, gE-TK- and PK- blocked the inhibition of IL-8 and neutrophil chemoattractant (KC), which was observed following inoculation with WT. In summary, the results obtained in FRECs may be used to predict the safety and immunogenicity characteristics of these mutants in vivo. Our study highlights the value of the FREC system for studying replication kinetics/immune modulation factors of FHV-1 and screening prospective vaccine candidates before their use in experimental cats.

The Establishment of a Novel In Vitro System for Culturing Cytauxzoon felis

A Novel Vaccine Strategy to Prevent Cytauxzoonosis in Domestic Cats.

Transmission of Cytauxzoon felis by injection of Amblyomma americanum salivary glands

In Vitro Modeling of Feline Morbillivirus Infections Using Primary Feline Kidney Cells

Development of Toxoplasma gondii Chinese I genotype Wh6 Strain in Cat Intestinal Epithelial Cells

In vitro production of cat-restricted Toxoplasma pre-sexual stages by epigenetic reprogramming

In vitro production of cat-restricted Toxoplasma pre-sexual stages

Isolation and characterization of Chlamydia felis and its pathogenesis in cats

Establishment of Full-length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats

An experimental genetically attenuated live vaccine to prevent transmission of Toxoplasma gondii by cats

Evaluation of immunogenicity and protection of the Mic1-3 knockout Toxoplasma gondii live attenuated strain in the feline host

Primary culture of cat intestinal epithelial cells in vitro and the cDNA library construction

First clinical case report of Cytauxzoon sp. infection in a domestic cat in France

Local pulmonary immune responses in domestic cats naturally infected with Cytauxzoon felis

Assessment of the Protective Efficacy of a Feline Calicivirus Inactivated Vaccine Using in Vivo FCV CH-JL2 Infection

Viral replication and innate immunity of feline herpesvirus-1 virulence-associated genes in feline respiratory epithelial cells

Induction of a systemic antiviral state in vivo in the domestic cat with a class A CpG oligonucleotide

In Vitro Growth, Receptor Usage and Pathogenesis of Feline Morbillivirus in the Natural Host

Development and Application of an In Vitro Tick Feeding System to Identify Ixodes Tick Environment-Induced Genes of the Lyme Disease Agent, Borrelia burgdorferi

In vitro cultivation methods for coccidian parasite research

Preparation of a novel type I feline coronavirus virus-like particle vaccine and its immunogenicity in mice and cats